Evaluation of quality of life in patients with bruxism and orofacial pain after treatment with botulinum toxin - randomized, double-blind clinical trial
Introduction: Botulinum toxin is produced by the bacterium Clostridium botulinum and the clinical applications of this toxin have become common over the last 30 years with predictable results. Objective: To evaluate the improvement in the quality of life of bruxism patients with my ofascial pain after the application of botulinum toxin. Method: In this randomized, double-blind controlled clinical study, 30 female patients were selected aged between 18 and 40 years who presented bruxism with orofacial pain.